Watchmaker Genomics Licenses CRISPR-Cas9 Intellectual Property from Caribou Biosciences to Increase Throughput and Reduce Sequencing Cost per Sample

Watchmaker Genomics, an innovator in high-performance solutions for next-generation sequencing (NGS), today announced a non-exclusive license with Caribou Biosciences, Inc., a leading clinical-stage ...
GEN

Watchmaker Genomics and Revvity Team to Automate and Streamline NGS Library Preparation

Watchmaker Genomics says it will collaborate with Revvity to automate and verify methods for all of its DNA and RNA library preparation kits on the Sciclone™ G3 NGSx liquid handling workstation. The ...